Demographic and hematologic characteristics of 90 patients with myeloproliferative disorders at the time of study
. | . | . | CIMF . | . | . | |
|---|---|---|---|---|---|---|
. | PV . | ET . | Prefibrotic . | Fibrotic . | Post-PV MF . | |
| No. patients | 25 | 19 | 12 | 18 | 16 | |
| Age, y, median (range) | 53 (27-79) | 56 (27-76) | 47 (18-71) | 49 (24-76) | 63 (45-77) | |
| No. men/no. women | 11/14 | 5/14 | 2/10 | 7/11 | 11/5 | |
| Hemoglobin level, g/L, median (range) | 173 (164-203) | 141 (120-165) | 140 (122-154) | 130 (98-152) | 126 (85-165) | |
| WBC count, × 109/L, median (range) | 9.2 (5.1-14.5) | 8.0 (5.1-12.5) | 10.8 (5.4-15.7) | 9.9 (5.3-13.9) | 15.1 (4.1-98.0) | |
| PLT count, × 109/L, median (range) | 642 (196-1170) | 789 (631-1197) | 773 (543-1053) | 842 (138-1810) | 309 (151-853) | |
| Splenomegaly, no. | 8 | 0 | 0 | 11 | 15 | |
. | . | . | CIMF . | . | . | |
|---|---|---|---|---|---|---|
. | PV . | ET . | Prefibrotic . | Fibrotic . | Post-PV MF . | |
| No. patients | 25 | 19 | 12 | 18 | 16 | |
| Age, y, median (range) | 53 (27-79) | 56 (27-76) | 47 (18-71) | 49 (24-76) | 63 (45-77) | |
| No. men/no. women | 11/14 | 5/14 | 2/10 | 7/11 | 11/5 | |
| Hemoglobin level, g/L, median (range) | 173 (164-203) | 141 (120-165) | 140 (122-154) | 130 (98-152) | 126 (85-165) | |
| WBC count, × 109/L, median (range) | 9.2 (5.1-14.5) | 8.0 (5.1-12.5) | 10.8 (5.4-15.7) | 9.9 (5.3-13.9) | 15.1 (4.1-98.0) | |
| PLT count, × 109/L, median (range) | 642 (196-1170) | 789 (631-1197) | 773 (543-1053) | 842 (138-1810) | 309 (151-853) | |
| Splenomegaly, no. | 8 | 0 | 0 | 11 | 15 | |
WBC indicates white blood cell; PLT, platelet.